Unknown

Dataset Information

0

Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation.


ABSTRACT: Chemotherapies are known often to induce severe gastrointestinal tract toxicity but the underlying mechanism remains unclear. This study considers the widely applied cytotoxic agent irinotecan (CPT-11) as a representative agent and demonstrates that treatment induces massive release of double-strand DNA from the intestine that accounts for the dose-limiting intestinal toxicity of the compound. Specifically, "self-DNA" released through exosome secretion enters the cytosol of innate immune cells and activates the AIM2 (absent in melanoma 2) inflammasome. This leads to mature IL-1? and IL-18 secretion and induces intestinal mucositis and late-onset diarrhoea. Interestingly, abrogation of AIM2 signalling, either in AIM2-deficient mice or by a pharmacological inhibitor such as thalidomide, significantly reduces the incidence of drug-induced diarrhoea without affecting the anticancer efficacy of CPT-11. These findings provide mechanistic insights into how chemotherapy triggers innate immune responses causing intestinal toxicity, and reveal new chemotherapy regimens that maintain anti-tumour effects but circumvent the associated adverse inflammatory response.

SUBMITTER: Lian Q 

PROVIDER: S-EPMC5518874 | biostudies-other | 2017 Jun

REPOSITORIES: biostudies-other

altmetric image

Publications

Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation.

Lian Qiaoshi Q   Xu Jun J   Yan Shanshan S   Huang Min M   Ding Honghua H   Sun Xiaoyu X   Bi Aiwei A   Ding Jian J   Sun Bing B   Geng Meiyu M  

Cell research 20170414 6


Chemotherapies are known often to induce severe gastrointestinal tract toxicity but the underlying mechanism remains unclear. This study considers the widely applied cytotoxic agent irinotecan (CPT-11) as a representative agent and demonstrates that treatment induces massive release of double-strand DNA from the intestine that accounts for the dose-limiting intestinal toxicity of the compound. Specifically, "self-DNA" released through exosome secretion enters the cytosol of innate immune cells a  ...[more]

Similar Datasets

| S-EPMC6204211 | biostudies-literature
| S-EPMC5760693 | biostudies-literature
| S-EPMC7958902 | biostudies-literature
| S-EPMC4748295 | biostudies-literature
| S-EPMC5319029 | biostudies-literature
| S-EPMC9481235 | biostudies-literature
| S-EPMC5733693 | biostudies-literature
| S-EPMC7788527 | biostudies-literature
| S-EPMC8038646 | biostudies-literature
| S-EPMC6368560 | biostudies-literature